Recover Investment Losses: Class Action Initiated Against Capricor Therapeutics, Inc. (CAPR)
Levi & Korsinsky announced a class action lawsuit against Capricor Therapeutics alleging securities fraud related to the Deramiocel BLA submission. The complaint claims the company adopted unapproved changes to statistical analysis plans, creating a risk that the FDA could find clinical results insufficient for approval.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.